1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
FIGURE 1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SEGMENTATION 26
1.3.2 INCLUSIONS & EXCLUSIONS OF THE STUDY 27
1.3.3 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 28
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28
1.5 STAKEHOLDERS 28
1.6 SUMMARY OF CHANGES 29

2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.2 PRIMARY DATA 32
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET ESTIMATION METHODOLOGY 35
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
2.2.1 PRODUCT-BASED MARKET ESTIMATION 36
2.2.2 VOLUME-BASED MARKET ESTIMATION 37
FIGURE 6 MARKET SIZE ESTIMATION: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 37
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
2.3 COVID-19 HEALTH ASSESSMENT 39
2.4 COVID-19 ECONOMIC ASSESSMENT 39
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 40
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 40
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 41
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 42
2.7 DATA TRIANGULATION 43
FIGURE 10 DATA TRIANGULATION 43
2.8 RESEARCH ASSUMPTIONS 44
2.9 RESEARCH LIMITATIONS 44

3 EXECUTIVE SUMMARY 45
FIGURE 11 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 45
FIGURE 12 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2021 VS. 2026 (USD MILLION) 46
FIGURE 13 HOSPITALS & SURGICAL CENTERS TO LEAD IN NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY APPLICATIONS DURING THE FORECAST PERIOD 47
FIGURE 14 NORTH AMERICA TO DOMINATE THE NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET DURING THE FORECAST PERIOD 48

4 PREMIUM INSIGHTS 49
4.1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW 49
FIGURE 15 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET DEMAND FOR INTERVENTIONAL NEUROLOGY PRODUCTS 49
4.2 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 50
FIGURE 16 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES TO LEAD NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 50
4.3 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET, BY REGION 51
FIGURE 17 EMBOLIC COILS TO LEAD THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 51
4.4 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY 52
FIGURE 18 CEREBRAL ANEURYSM TO DOMINATE NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY, 2021 VS. 2026 52
4.5 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY 53
FIGURE 19 CHINA AND INDIA TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 53

5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 20 NEUROVASCULAR /INTERVENTIONAL NEUROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Large target patient population 55
FIGURE 21 PROPORTION OF GERIATRIC POPULATION TO TOTAL WORLD POPULATION, BY COUNTRY, 2020 VS. 2030 (MILLION PEOPLE) 56
5.2.1.2 Increasing product launches and commercialization 56
TABLE 2 PRODUCT APPROVALS IN THE NEUROVASCULAR DEVICES MARKET, 2020-2021 57
5.2.1.3 Favorable reimbursement scenario 57
TABLE 3 US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES, 2020 57
5.2.1.4 Expansion of healthcare infrastructure across emerging markets 58
FIGURE 22 GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE (GDP): DEVELOPED VS. DEVELOPING COUNTRIES, 2015 VS. 2019 58
5.2.1.5 Growth in market demand for effective neurovascular devices 59
5.2.2 RESTRAINTS 59
5.2.2.1 Dearth of skilled neurosurgeons 59
5.2.2.2 High procedural cost of neurovascular surgeries and related products 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Increase in the number of research activities in the field of neurovascular therapies 60
FIGURE 23 ONGOING CLINICAL TRIALS IN THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET 61
5.2.3.2 Rise in demand for minimally invasive neurosurgical procedures 61
5.2.4 CHALLENGE 62
5.2.4.1 Stringent regulations 62
5.3 SUPPLY CHAIN ANALYSIS 64
FIGURE 24 SUPPLY CHAIN ANALYSIS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2020 64
5.3.1 ROLE IN SUPPLY CHAIN 65
5.4 ECOSYSTEM ANALYSIS 65
5.5 VALUE CHAIN ANALYSIS 66
FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE REGULATION AND DISTRIBUTION STAGES 66
5.6 PORTER'S FIVE FORCES ANALYSIS 66
5.6.1 OVERVIEW 66
TABLE 4 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS 67
5.6.2 THREAT OF NEW ENTRANTS 67
FIGURE 26 THREAT OF NEW ENTRANTS 67
5.6.3 THREAT OF SUBSTITUTES 68
FIGURE 27 THREAT OF SUBSTITUTES 68
5.6.4 BARGAINING POWER OF SUPPLIERS 68
FIGURE 28 BARGAINING POWER OF SUPPLIERS 68
5.6.5 BARGAINING POWER OF BUYERS 69
FIGURE 29 BARGAINING POWER OF BUYERS 69
5.6.6 DEGREE OF COMPETITION 69
FIGURE 30 DEGREE OF COMPETITION 70
5.7 REGULATORY LANDSCAPE 70
5.7.1 NORTH AMERICA 70
5.7.1.1 US 70
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 71
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
5.7.1.2 Canada 71
5.7.2 EUROPE 72
5.7.3 APAC 72
5.7.3.1 China 72
5.7.3.2 Japan 72
5.7.3.3 India 73
5.7.3.4 South Korea 73
5.8 REIMBURSEMENT SCENARIO 73
TABLE 7 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2019 73
5.9 PRICING TREND ANALYSIS 77
TABLE 8 AVERAGE PRICE OF NEUROVASCULAR DEVICES, BY COUNTRY, 2020 (USD) 77
5.10 COVID-19 IMPACT ON NEUROVASCULAR/INTERVENTIONAL NEUROLOGY DEVICES MARKET 78
5.11 PATENT DETAILS 78
TABLE 9 PATENT DETAILS 78
FIGURE 31 PATENT ANALYSIS, 2011-2021 79

6 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT 80
6.1 INTRODUCTION 81
TABLE 10 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 81
TABLE 11 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (UNITS) 82
6.2 ANEURYSM COILING & EMBOLIZATION DEVICES 82
TABLE 12 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION) 83
TABLE 13 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (UNITS) 84
TABLE 14 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION) 84
TABLE 15 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 85
TABLE 16 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 85
6.2.1 EMBOLIC COILS 86
TABLE 17 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 86
TABLE 18 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019-2026 (USD MILLION) 87
TABLE 19 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019-2026 (UNITS) 87
6.2.1.1 Bare detachable coils 88
6.2.1.1.1 Clinical concerns related to the recurrence of brain aneurysms after treatment with bare detachable coils to limit the demand 88
TABLE 20 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR BARE DETACHABLE COILS, BY REGION, 2019-2026 (USD MILLION) 88
6.2.1.2 Coated detachable coils 89
6.2.1.2.1 High product prices to limit adoption in the forecast period 89
TABLE 21 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR COATED DETACHABLE COILS, BY REGION, 2019-2026 (USD MILLION) 89
6.2.2 FLOW DIVERSION DEVICES 90
6.2.2.1 Increase in R&D activities for flow diverters to support demand in the forecast period 90
TABLE 22 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019-2026 (USD MILLION) 91
TABLE 23 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019-2026 (UNITS) 91
6.2.3 LIQUID EMBOLIC AGENTS 92
6.2.3.1 Growth in application in the treatment of AVM & AVF to propel demand 92
TABLE 24 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019-2026 (USD MILLION) 92
TABLE 25 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019-2026 (UNITS) 93
6.3 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS 93
TABLE 26 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION) 94
TABLE 27 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019-2026 (UNITS) 94
TABLE 28 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION) 95
TABLE 29 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 95
TABLE 30 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY END USER, 2019-2026 (USD MILLION) 96
6.3.1 CAROTID ARTERY STENTS 96
6.3.1.1 Rise in public-private research funding to support innovative product development 96
TABLE 31 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019-2026 (USD MILLION) 97
TABLE 32 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019-2026 (UNITS) 98
6.3.2 EMBOLIC PROTECTION DEVICES 98
6.3.2.1 Associated technical limitations to restrain the market growth 98
TABLE 33 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2019-2026 (USD MILLION) 99
TABLE 34 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR DISTAL FILTER DEVICES, BY REGION, 2019-2026 (UNITS) 100
6.3.3 BALLOON CATHETERS 100
6.3.3.1 Availability of specialized products to support market growth 100
TABLE 35 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019-2026 (USD MILLION) 101
TABLE 36 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019-2026 (UNITS) 101
6.4 SUPPORT DEVICES 101
TABLE 37 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019-2026 (USD MILLION) 102
TABLE 38 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019-2026 (UNITS) 102
TABLE 39 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY REGION, 2019-2026 (USD MILLION) 103
TABLE 40 SUPPORT DEVICES SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 103
TABLE 41 SUPPORT DEVICES SIZE, BY END USER, 2019-2026 (USD MILLION) 104
6.4.1 MICROCATHETERS 104
6.4.1.1 Ongoing technological advancements in the field of neurovascular microcatheters to support market growth 104
TABLE 42 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019-2026 (USD MILLION) 105
TABLE 43 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019-2026 (UNITS) 105
6.4.2 GUIDEWIRES 106
6.4.2.1 Higher application in stenting procedures to support market growth 106
TABLE 44 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019-2026 (USD MILLION) 106
TABLE 45 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019-2026 (UNITS) 107
6.5 NEUROTHROMBECTOMY DEVICES 107
TABLE 46 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION) 108
TABLE 47 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019-2026 (UNITS) 108
TABLE 48 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION) 109
TABLE 49 NEUROTHROMBECTOMY DEVICES SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 109
TABLE 50 NEUROTHROMBECTOMY DEVICES SIZE, BY END USER, 2019-2026 (USD MILLION) 110
6.5.1 CLOT RETRIEVAL DEVICES 110
6.5.1.1 Greater availability of innovative stent clot retrievers to promote demand in the forecast period 110
TABLE 51 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019-2026 (USD MILLION) 111
TABLE 52 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019-2026 (UNITS) 111
6.5.2 SUCTION & ASPIRATION DEVICES 112
6.5.2.1 Development and commercialization of novel devices to support market growth 112
TABLE 53 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019-2026 (USD MILLION) 112
TABLE 54 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019-2026 (UNITS) 113
6.5.3 SNARES 113
6.5.3.1 Limited procedural benefits to limit the adoption in the forecast period 113
TABLE 55 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019-2026 (USD MILLION) 114
TABLE 56 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019-2026 (UNITS) 114

7 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY 115
7.1 INTRODUCTION 116
TABLE 57 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 116
TABLE 58 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2019-2026 (USD MILLION) 116
7.2 CEREBRAL ANEURYSMS 117
7.2.1 HIGH RISK OF ANEURYSM RECURRENCE AFTER COILING PROCEDURE TO SUPPORT MARKET GROWTH 117
TABLE 59 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CEREBRAL ANEURYSMS, BY REGION, 2019-2026 (USD MILLION) 117
7.3 ISCHEMIC STROKES 118
7.3.1 GROWTH IN THE NUMBER OF PATIENTS SUFFERING FROM STROKES TO INCREASE THE DEMAND FOR NEUROVASCULAR DEVICES 118
TABLE 60 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ISCHEMIC STROKES, BY REGION, 2019-2026 (USD MILLION) 118
7.4 CAROTID ARTERY STENOSIS 119
7.4.1 RISE IN THE OCCURENCE OF ARTERY STENOSES TO BOOST THE MARKET 119
TABLE 61 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CAROTID ARTERY STENOSIS, BY REGION, 2019-2026 (USD MILLION) 119
7.5 ARTERIOVENOUS MALFORMATION & FISTULAS 120
7.5.1 LACK OF SKILLED NEUROSURGEONS CAN RESTRAIN MARKET GROWTH 120
TABLE 62 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2019-2026 (USD MILLION) 120
7.6 OTHER DISEASE PATHOLOGIES 121
7.6.1 INCREASE IN THE PATIENT POPULATION FOR TARGET DISEASES TO BOOST THE MARKET 121
TABLE 63 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2019-2026 (USD MILLION) 121

8 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY END USER 122
8.1 INTRODUCTION 123
TABLE 64 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 123
8.2 HOSPITALS & SURGICAL CENTERS 124
8.2.1 LARGEST END USERS OF NEUROVASCULAR DEVICES 124
TABLE 65 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN HOSPITALS & SURGICAL CENTERS, BY REGION, 2019-2026 (USD MILLION) 124
8.3 AMBULATORY CARE CENTERS 125
8.3.1 INCREASE IN THE NUMBER OF ACCS LIKELY TO BOOST THE MARKET 125
TABLE 66 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN AMBULATORY CARE CENTERS, BY REGION, 2019-2026 (USD MILLION) 125
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 126
8.4.1 ONGOING DEVELOPMENT OF COST-EFFECTIVE AND TECHNOLOGICALLY ADVANCED DEVICES TO SUPPORT THE GROWTH OF THIS SEGMENT 126
TABLE 67 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2019-2026 (USD MILLION) 126

9 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION 127
9.1 INTRODUCTION 128
TABLE 68 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2019-2026 (USD MILLION) 128
9.2 NORTH AMERICA 129
TABLE 69 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION) 130
TABLE 70 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 130
TABLE 71 NORTH AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 131
TABLE 72 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 131
TABLE 73 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 132
TABLE 74 NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 132
TABLE 75 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 133
TABLE 76 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 133
TABLE 77 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 134
FIGURE 32 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 135
9.2.1 US 136
9.2.1.1 Largest share of the North American market 136
TABLE 78 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 136
TABLE 79 US: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 137
TABLE 80 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 137
TABLE 81 US: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 138
TABLE 82 US: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 138
TABLE 83 US: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 139
9.2.2 CANADA 139
9.2.2.1 The high incidence of neurovascular diseases to support market growth 139
TABLE 84 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 140
TABLE 85 CANADA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 140
TABLE 86 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 141
TABLE 87 CANADA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 141
TABLE 88 CANADA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 142
TABLE 89 CANADA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 142
9.3 EUROPE 143
TABLE 90 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION) 143
TABLE 91 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 144
TABLE 92 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 144
TABLE 93 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 145
TABLE 94 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 145
TABLE 95 EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 146
TABLE 96 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 146
TABLE 97 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 147
TABLE 98 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 147
9.3.1 GERMANY 148
9.3.1.1 Largest share of the market in Europe in 2020 148
TABLE 99 GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 148
TABLE 100 GERMANY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 149
TABLE 101 GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 149
TABLE 102 GERMANY: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 150
TABLE 103 GERMANY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 150
TABLE 104 GERMANY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 151
9.3.2 FRANCE 151
9.3.2.1 Increase in awareness in the country regarding incidences of strokes 151
TABLE 105 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 152
TABLE 106 FRANCE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 152
TABLE 107 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 153
TABLE 108 FRANCE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 153
TABLE 109 FRANCE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 154
TABLE 110 FRANCE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 154
9.3.3 UK 154
9.3.3.1 Growth in government initiatives to support market demand 154
TABLE 111 UK: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 155
TABLE 112 UK: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 155
TABLE 113 UK: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 156
TABLE 114 UK: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 156
TABLE 115 UK: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 157
TABLE 116 UK: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 157
9.3.4 ITALY 157
9.3.4.1 Well-established healthcare infrastructure to aid the growth of the neurovascular devices market 157
TABLE 117 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 158
TABLE 118 ITALY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 158
TABLE 119 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 159
TABLE 120 ITALY: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 159
TABLE 121 ITALY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 160
TABLE 122 ITALY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 160
9.3.5 SPAIN 161
9.3.5.1 Rise in the number of clinical trials to support the growth of the neurovascular devices market 161
TABLE 123 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 161
TABLE 124 SPAIN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 162
TABLE 125 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 162
TABLE 126 SPAIN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 163
TABLE 127 SPAIN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 163
TABLE 128 SPAIN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 164
9.3.6 REST OF EUROPE 164
TABLE 129 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 165
TABLE 130 ROE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 165
TABLE 131 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 166
TABLE 132 ROE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 166
TABLE 133 ROE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 167
TABLE 134 ROE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 167
9.4 APAC 167
TABLE 135 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION) 168
TABLE 136 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 169
TABLE 137 APAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 169
TABLE 138 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 170
TABLE 139 APAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 170
TABLE 140 APAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 171
TABLE 141 APAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 171
TABLE 142 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 172
TABLE 143 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 172
FIGURE 33 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT 173
9.4.1 JAPAN 174
9.4.1.1 Favorable reimbursement policy in the country to support market growth 174
TABLE 144 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 174
TABLE 145 JAPAN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 175
TABLE 146 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 175
TABLE 147 JAPAN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 176
TABLE 148 JAPAN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 176
TABLE 149 JAPAN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 177
9.4.2 CHINA 177
9.4.2.1 Expansion by key market players in the region to drive market growth 177
TABLE 150 CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 178
TABLE 151 CHINA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 178
TABLE 152 CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 179
TABLE 153 CHINA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 179
TABLE 154 CHINA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 180
TABLE 155 CHINA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 180
9.4.3 INDIA 180
9.4.3.1 Increase in government initiatives to support the demand for neurovascular devices 180
TABLE 156 INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 181
TABLE 157 INDIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 182
TABLE 158 INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 182
TABLE 159 INDIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 183
TABLE 160 INDIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 183
TABLE 161 INDIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 184
9.4.4 AUSTRALIA 184
9.4.4.1 Rise in disease prevalence Australia to augment market demand 184
TABLE 162 AUSTRALIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 185
TABLE 163 AUSTRALIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 185
TABLE 164 AUSTRALIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 186
TABLE 165 AUSTRALIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 186
TABLE 166 AUSTRALIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 187
TABLE 167 AUSTRALIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 187
9.4.5 SOUTH KOREA 187
9.4.5.1 Supportive government initiatives to drive the neurovascular devices market 187
TABLE 168 SOUTH KOREA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 188
TABLE 169 SOUTH KOREA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 188
TABLE 170 SOUTH KOREA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 189
TABLE 171 SOUTH KOREA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 189
TABLE 172 SOUTH KOREA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 190
TABLE 173 SOUTH KOREA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 190
9.4.6 REST OF APAC 191
TABLE 174 ROAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 191
TABLE 175 ROAPAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 192
TABLE 176 RAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 192
TABLE 177 ROAPAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 193
TABLE 178 ROAPAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 193
TABLE 179 ROAPAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 194
9.5 LATIN AMERICA 194
TABLE 180 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION) 194
TABLE 181 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 195
TABLE 182 LATIN AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 195
TABLE 183 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 196
TABLE 184 LATIN AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 196
TABLE 185 LATIN AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 197
TABLE 186 LATIN AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 197
TABLE 187 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019-2026 (USD MILLION) 198
TABLE 188 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019-2026 (USD MILLION) 198
9.5.1 BRAZIL 199
9.5.1.1 Increase in awareness about neurovascular devices to increase the demand in Brazil 199
TABLE 189 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 199
TABLE 190 BRAZIL: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 200
TABLE 191 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 200
TABLE 192 BRAZIL: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 201
TABLE 193 BRAZIL: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 201
TABLE 194 BRAZIL: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 202
9.5.2 MEXICO 202
9.5.2.1 Growth in patient population to lead to market growth 202
TABLE 195 MEXICO: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 203
TABLE 196 MEXICO: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 203
TABLE 197 MEXICO: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 204
TABLE 198 MEXICO: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 204
TABLE 199 MEXICO: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 205
TABLE 200 MEXICO: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 205
9.5.3 REST OF LATIN AMERICA 206
TABLE 201 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 206
TABLE 202 ROLATAM: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION) 207
TABLE 203 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019-2026 (USD MILLION) 207

Please contact our Customer Support Center to get the complete Table of Contents